An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Investigational Treatment Gaining Traction Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to message these accounts directly for supplier links, while also obtaining promotional offers.
Thriving Trade on Social Networks
Additionally, a flourishing market exists on messaging services, where communities with numerous of participants share comparison images, injection guides and assertions of next-day UK delivery. Vendors market the substance there before directing buyers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Experts Express Concerns
However, physicians and chemists have warned that the distribution of what remains an unapproved medication in the UK is worrisome and could result in individuals injecting substances of uncertain source.
Several experts said the popularity for the experimental drug could be linked to the increasing price of approved weight loss products such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Response and Material Elimination
According to TikTok, the service has taken down violative content and banned related keywords and query recommendations. The company said it was dedicated to maintaining the platform safe and investing in strengthening enforcement strategies.
Digital Marketplace Activities
Investigations also discovered groups with up to nine thousand participants marketing the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays channels with numerous of users, filled with photos of weight loss, positive reviews and detailed guides for preparing or administering at home.
Within minutes of joining one group, a seller posted contact information, where most transactions occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.
Product Details and Costs
Inside these groups, messages display dark colored parcels with postal service labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When asked how long a injector should last, vendors give contradictory responses ranging from a several days to “depends on your body”.
Platform Moderation and Security Measures
A representative for Telegram stated it actively moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting substances they can’t verify. Although the research behind this drug is sound, these digital versions may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.
Her team has already encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a company experimental product not yet approved … may subject patients to possibly serious health risks”.
